Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC
Clinical trial NCT07516015 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07516015
- Sponsor
- Nanjing Tianyinshan Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-10
- Primary completion
- 2029-09-30
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.